The Therapeutic Goods Administration (TGA) is advising health professionals and consumers of a current shortage for all strengths of PROGYNOVA estradiol valerate tablets. Due to manufacturing issues the shortage is expected to continue until May 2022.
SHIRLEY, N.Y., June 3, 2020 /PRNewswire/ -- American Regent announces the introduction and availability of Estradiol Valerate Injection, USP – AO Rated and therapeutically equivalent to Delestrogen®1,2.
Hikma`s Generic Estradiol Valerate Receives Approval In US
Anvisa registers new generic drugs
Watson Labs Generic Estradiol Valerate And Dienogest Receives Approval In Us
Watson Lab`s Generic Dienogest; Estradiol Valerate approved in US for heavy menstrual bleeding
Alvogen, the next generation pharmaceuticals company, has acquired five hormonal branded products from Bayer Pharma AG in Russia and CIS. The products acquired are Klimonorm (hormone replacement therapy), Progynova (hormone replacement therapy), Triquilar (female contraception) and Microgynon (female contraception) and Climene (hormone replacement therapy).
NCE Exclusivity Challenges are hot! Hot! HOT! Ferring Lets Loose with the Latest Lawsuit Challenging Denial of NCE Exclusivity for Colon Cleansing Drug
Advanced Physician Solutions, Inc. initiates Class II recall of Estradiol Cypionate due to Lack of Assurance of Sterility
Menopausal HT Not Tied to Greater Death Risk